EyeGene Inc. (KOSDAQ:185490)
South Korea · Delayed Price · Currency is KRW 3,470.00
-150.00 (-4.14%)
At close: Jul 18, 2025, 3:30 PM KST
EyeGene Revenue
EyeGene had revenue of 817.71M KRW in the quarter ending March 31, 2025, with 56.26% growth. This brings the company's revenue in the last twelve months to 3.65B, up 27.15% year-over-year. In the year 2024, EyeGene had annual revenue of 3.36B with 7.37% growth.
Revenue (ttm)
3.65B
Revenue Growth
+27.15%
P/S Ratio
25.70
Revenue / Employee
74.49M
Employees
49
Market Cap
93.79B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 308.10T |
| SK hynix | 71.40T |
| LG Energy Solution | 25.76T |
| Samsung Biologics | 4,898.69B |
| Hyundai Motor Company | 178.98T |
| Hanwha Aerospace | 15.28T |
| Doosan Enerbility | 15.88T |
| KB Financial Group | 14.93T |